BRCA1: a movement toward cancer prevention

Por Alli, Elizabeth, Ford, James M
Publicado no Mol Cell Oncol (2015)

Synergistic chemosensitivity of triple-negative breast cancer cell lines to PARP inhibition, gemcitabine and cisplatin

Por Hastak, Kedar, Alli, Elizabeth, Ford, James M.
Publicado em 2010

Defective Repair of Oxidative DNA Damage in Triple-negative Breast Cancer Confers Sensitivity to Inhibition of Poly(ADP-ribose) Polymerase

Por Alli, Elizabeth, Sharma, Vandana B., Sunderesakumar, Preethi, Ford, James M.
Publicado em 2009

Therapeutic targeting of BRCA1-mutated breast cancers with agents that activate DNA repair

Por Alli, Elizabeth, Solow-Cordero, David, Casey, Stephanie C., Ford, James M.
Publicado no Cancer Res (2014)

Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells

Por Alli, Elizabeth, Sharma, Vandana B, Hartman, Anne-Renee, Lin, Patrick S, McPherson, Lisa, Ford, James M
Publicado em 2011